Analyst Recommendations
44.61 -0.64(-1.41%)09/06/2024
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)
2024: Total Recommendations Consensus
| To Grade | # of Recommendations |
|---|---|
| Buy | 12 |
| Equal-Weight | 5 |
| Sector Perform | 2 |
| Neutral | 1 |
| Outperform | 1 |
| Overweight | 1 |
| Underweight | 1 |
| Hold | 1 |
| Market Outperform | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades